News and Events

Blog Post Filter

In this application story we take a closer look at the results of the Svar Complement Assays when analyzing how the complement system is affected by a drug candidate. We showcase results from the study of inhibitory effect of eculizumab on the complement system using two biomarker assays, one ... Read more
In some patients, COVID-19 can cause acute respiratory distress syndrome (ARDS). This is a very serious condition that causes alveolar damage to the lungs, can cause pulmonary thrombosis and often requires ventilator support. A majority of patients undergoing treatment for COVID-19 in intensive ... Read more
Every drug can produce some kind of unwanted effects – ranging from mild to severe – in addition to its intended effect Read more
They say hindsight is 2020 – and as 2021 is just around the corner – Let Svar Life Science help you obtain perfect vision for your ongoing and new drug development projects in 2021! We ended the year with a focus on retinal gene therapy – an area that is expected to continue to expand exponentially ... Read more